These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4281242)

  • 1. [Results of observing the immunity dynamics in those inoculated with live Leningrad-16 and Schwartz measles vaccines].
    Zetilova LP; Bolotovskiĭ VM; Trufanova II; Abzalov KA; Duramshina NS
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):95-8. PubMed ID: 4281242
    [No Abstract]   [Full Text] [Related]  

  • 2. [Postvaccinal immunity in those inoculated with live measles vaccine].
    Popov VF; Parkhomov II; Semen'kova LI
    Vopr Virusol; 1973; 18(4):455-8. PubMed ID: 4786167
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological effectiveness of a booster inoculation against measles in children remaining seronegative after vaccination].
    Bolomovskiĭ VM; Gelikman BG; Titova NS; Slavnitskaia IV; Auzinia AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Jul; (7):100-6. PubMed ID: 6333122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to measles in children vaccinated before and after 1 year of age.
    Reynolds DW; Start A
    Am J Dis Child; 1972 Dec; 124(6):848-50. PubMed ID: 4639220
    [No Abstract]   [Full Text] [Related]  

  • 6. Measles (rubeola) susceptibility among elementary schoolchildren.
    Kalis JM; Quie PG; Balfour HH
    Am J Epidemiol; 1975 Jun; 101(6):527-31. PubMed ID: 1155431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiological and serological study of the causes of measles morbidity in children inoculated against this infection].
    Chudnaia LM; Shekhter AB; Fastovskaia BN; Oleĭnikova AN
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Sep; 50(9):7-10. PubMed ID: 4789671
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Fourth report to the medical research council by the measles sub-committee of the committee on development of vaccines and immunisation procedures.
    Lancet; 1977 Sep; 2(8038):571-5. PubMed ID: 71396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and serological evaluation of live measles vaccine in India.
    Phadke MA; Rodrigues JJ; Mehta JM; Ayachit V
    Indian Pediatr; 1983 Aug; 20(8):573-6. PubMed ID: 6662582
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measles: notes on epidemiology and prevention, including the military community].
    Zardi O
    Riv Med Aeronaut Spaz; 1979; 42(1-2):124-60. PubMed ID: 400041
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunostructure of school-age children inoculated against measles].
    Bolotovskiĭ VM; Gelikman BG; Slavnitskaia IV; Glinskaia EV; Auzinia AV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Feb; (2):83-7. PubMed ID: 6608840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 15. [Epidemiological and immunological study of the duration and intensity of postvaccinal immunity against measles].
    Bolotovskiĭ VM; Gelikman BG; Kibrik LI; Urman IS
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):125. PubMed ID: 1085088
    [No Abstract]   [Full Text] [Related]  

  • 16. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
    Willis MF; Warburton MF
    Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 18. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus.
    Aleksandrowicz J; Polna I; Sadowski W
    Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined measles-rubella vaccines. Virus dose and serologic response.
    Landrigan PJ; Murphy KB; Meyer HM; Parkman PD; Eddins DL; Witte JJ
    Am J Dis Child; 1973 Jan; 125(1):65-7. PubMed ID: 4683961
    [No Abstract]   [Full Text] [Related]  

  • 20. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.